Moderna said yesterday that its coronavirus (Covid-19) vaccine is 96% effective among youths aged 12-17, according to the results of its first clinical trials. Two-thirds of the 3,235 participants in trials in the United States received the vaccine and one-third were given a placebo. The study “showed vaccine efficacy against Covid-19 of 96%; mRNA-1273 was generally well tolerated with no serious safety concerns identified to date”. Tests detected 12 cases of coronavirus 14 days after the first shot. For these intermediate results, participants were followed up on average 35 days after the second injection. The pharmaceutical company said that any side effects had been “mild or moderate in
Hence then, the article about moderna vaccine 96 effective in those aged 12 17 years study shows was published today ( ) and is available onGulf Times ( Qatar ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Moderna vaccine 96% effective in those aged 12-17 years, study shows )